Lili Yang1,2, Yaoyao Bian3, Zhengjun Li4, Yan Yan5, Junyi Li1, Wenlin Li2, Li Zeng1,2. 1. School of First Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. 2. Jingwen Library, Nanjing University of Chinese Medicine, Nanjing 210023, China. 3. School of Nursing, Nanjing University of Chinese Medicine, Nanjing 210023, China. 4. Management School, Lancaster University, Lancaster, LA1 4YW, UK. 5. Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Abstract
BACKGROUND: Ulcerative colitis (UC) is a chronic, relapsing and non-specific inflammatory disease, involving various genes and pathways in their pathogenesis. Increasing evidences have showed that microRNAs (miRNAs) act as key post-transcriptional regulators of gene expression in UC. This current study aimed to identify key miRNAs, potential target genes, and relevant pathways involved in UC to uncover their underlying molecular mechanisms by using bioinformatics analysis. METHODS: The mRNA and miRNA expression profiles were retrieved and downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) and miRNAs (DEMIs) were obtained by using the R software package. RESULTS: A total of 79 DEGs and 47 DEMIs were obtained. And a panel of miRNAs and their target mRNAs were identified. It showed that miR-1231 may be a key regulator for DUOX2 and TFF1. CCL11 may be potentially targeted by miR-625. MMP1 may play vital roles in the development of UC by regulating the miR-1228/PPAR signaling pathway. In addition, we validated the most significantly up/down-expressed miRNAs (miR-92b, miR-625) and two of their corresponding target mRNAs (AQP8 and TAGAP, CCL11 and CHI3L1) in colon tissues of UC models preliminarily. The results were consistent with the microarray analysis. CONCLUSIONS: These findings may provide new insights into representing key mechanisms associated with the development of UC. 2019 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Ulcerative colitis (UC) is a chronic, relapsing and non-specific inflammatory disease, involving various genes and pathways in their pathogenesis. Increasing evidences have showed that microRNAs (miRNAs) act as key post-transcriptional regulators of gene expression in UC. This current study aimed to identify key miRNAs, potential target genes, and relevant pathways involved in UC to uncover their underlying molecular mechanisms by using bioinformatics analysis. METHODS: The mRNA and miRNA expression profiles were retrieved and downloaded from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) and miRNAs (DEMIs) were obtained by using the R software package. RESULTS: A total of 79 DEGs and 47 DEMIs were obtained. And a panel of miRNAs and their target mRNAs were identified. It showed that miR-1231 may be a key regulator for DUOX2 and TFF1. CCL11 may be potentially targeted by miR-625. MMP1 may play vital roles in the development of UC by regulating the miR-1228/PPAR signaling pathway. In addition, we validated the most significantly up/down-expressed miRNAs (miR-92b, miR-625) and two of their corresponding target mRNAs (AQP8 and TAGAP, CCL11 and CHI3L1) in colon tissues of UC models preliminarily. The results were consistent with the microarray analysis. CONCLUSIONS: These findings may provide new insights into representing key mechanisms associated with the development of UC. 2019 Journal of Gastrointestinal Oncology. All rights reserved.
Authors: Sunil Thomas; Kevther Hoxha; Walker Alexander; John Gilligan; Rima Dilbarova; Kelly Whittaker; Andrew Kossenkov; George C Prendergast; James M Mullin Journal: J Cell Biochem Date: 2018-09-30 Impact factor: 4.429
Authors: Petra Talapka; Anikó Berkó; Lajos István Nagy; Lalitha Chandrakumar; Mária Bagyánszki; László Géza Puskás; Éva Fekete; Nikolett Bódi Journal: World J Gastroenterol Date: 2016-06-14 Impact factor: 5.742
Authors: Tereza Nováková; Táňa Macháčková; Jan Novák; Petr Hude; Július Godava; Víta Žampachová; Jan Oppelt; Filip Zlámal; Petr Němec; Helena Bedáňová; Ondřej Slabý; Julie Bienertová-Vašků; Lenka Špinarová; Jan Krejčí Journal: Cells Date: 2019-11-06 Impact factor: 6.600
Authors: Zhenxiang Rong; Yi Rong; Yingru Li; Lei Zhang; Jingwen Peng; Baojia Zou; Nan Zhou; Zihao Pan Journal: Front Oncol Date: 2020-02-21 Impact factor: 6.244